Tag: diabetes

March 21, 2019

OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial

OPKO Health (NASDAQ:OPK) has announced positive topline results from a Phase 2 dose escalation trial for OPK88003 to treat type...
December 10, 2018

4 Private Longevity Research Stocks to Watch

Calico is just one longevity research company that promises to make major headlines in the longevity investing space.
July 25, 2018

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries

Integrity Applications (OTCQB:IGAP) has announced it has entered into an exclusive distribution agreement with CuraTec Nordic, a Scandinavian medical device...
July 4, 2018

5 Top NASDAQ Pharma Stocks of Q2 2018

About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
June 12, 2018

Dexcom G6 CGM System Receives CE Mark

Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom...
May 17, 2018

Resverlogix CEO Discusses Phase 3 BETonMACE Clinical Trial

Aside from the recent funding and Phase 3 trial news, Resverlogix has many milestones for investors to look forward to...